glp 1 2 and 3 GLP-1 Receptor Agonists as Treatments for Type Diabetes Emerging Frontiers in GLP-1 Therapeutics:
Description
[21] A 2014 review found that the use of saxagliptin and alogliptin increased individuals' risk of developing heart failure, leading the FDA to add warnings to the labels of these drugs in 2016
E., Gishan, F
A second MDL involves sudden vision changes, optic nerve damage, loss of peripheral vision, blurred vision, or permanent blindness allegedly associated with NAION following semaglutide use
Potential Benefits for Endometriosis Reduced inflammation : Endometriosis is driven by chronic inflammation
